160 related articles for article (PubMed ID: 1246850)
21. New concept on atherogenesis and treatment of atherosclerotic diseases.
Shimamoto T
Jpn Heart J; 1972 Nov; 13(6):537-62. PubMed ID: 4631735
[No Abstract] [Full Text] [Related]
22. Partial suppression by pyridinolcarbamate of growth and necrosis of atherosclerotic lesions in swine subjected to an atherogenic regimen that produces advanced lesions.
Lee WM; Lee KT; Thomas WA
Exp Mol Pathol; 1979 Feb; 30(1):85-93. PubMed ID: 421864
[No Abstract] [Full Text] [Related]
23. [Evaluation of anginine in the treatment of cerebrovascular disorders (preliminary report)].
Majkowski J
Neurol Neurochir Pol; 1975; 9(3):381-8. PubMed ID: 1153068
[TBL] [Abstract][Full Text] [Related]
24. [Psychophysiological aspect of the therapeutic use of pyridinolcarbamate].
Sidorenko GI; Borisova GS; Sidorenko ER; Polonetskii LZ; Gelis LG
Kardiologiia; 1983 Mar; 23(3):66-71. PubMed ID: 6855067
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
Bagliani A; Borri P; Parravicini R
Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
[No Abstract] [Full Text] [Related]
26. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
Makinskiĭ AI; Safarov RN; Fondaminskaia LD; Semenova AS; Fedotova NN
Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
[No Abstract] [Full Text] [Related]
27. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
Hunyi L
Ther Hung; 1978; 26(2):77-80. PubMed ID: 684660
[No Abstract] [Full Text] [Related]
28. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
[No Abstract] [Full Text] [Related]
29. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate].
Guerrera G; Melina D
Clin Ter; 1980 Mar; 92(5):533-47. PubMed ID: 7449327
[No Abstract] [Full Text] [Related]
30. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
Hunyi L
Ther Hung; 1976; 24(2):67-71. PubMed ID: 982342
[No Abstract] [Full Text] [Related]
31. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
Parodi FA; Caputo G
Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761
[No Abstract] [Full Text] [Related]
32. [Combined intenkordin and corhormone treatment of ischemic heart disease].
Glukhen'kiĭ TT; Kuz'ko NV
Vrach Delo; 1974 May; 5(0):55-7. PubMed ID: 4407764
[No Abstract] [Full Text] [Related]
33. A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion.
Mishima Y; Kamiya K; Sakaguchi S; Kusaba A; Sakuma A
Angiology; 1977 Feb; 28(2):84-94. PubMed ID: 326097
[TBL] [Abstract][Full Text] [Related]
34. [Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate].
Notarbartolo A; Rini GB; Di Fede G
Boll Soc Ital Cardiol; 1973; 18(4):379-83. PubMed ID: 4807078
[No Abstract] [Full Text] [Related]
35. [Effect of Prodectin on various blood clotting factors].
Czaplicki S; Ostrowska B; Sułek K
Pol Tyg Lek; 1978 Sep; 33(39):1541-4. PubMed ID: 704456
[No Abstract] [Full Text] [Related]
36. A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.
Zelikovsky A; Urca I; Shaklai M; de Vries A
Jpn Heart J; 1973 Jan; 14(1):12-21. PubMed ID: 4541560
[No Abstract] [Full Text] [Related]
37. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
Orbetzova V; Jurukova Z; Orbetzova M
Artery; 1980; 8(6):560-9. PubMed ID: 7259535
[TBL] [Abstract][Full Text] [Related]
38. The effects of pyridinolcarbamate on induced atherosclerosis in cynomolgus monkeys (Macaca ira).
Malinow MR; McLaughlin P; Perley A
Atherosclerosis; 1972; 15(1):31-6. PubMed ID: 4111120
[No Abstract] [Full Text] [Related]
39. [Experience with polysponin therapy of atherosclerosis].
Milimovka ME; Konovalov MN; Rybnikov NI; Dimant MI
Vrach Delo; 1971 Jan; (1):63-5. PubMed ID: 5576585
[No Abstract] [Full Text] [Related]
40. [Use of the antikinin preparation prodectin in the complex treatment of pulmonary tuberculosis patients].
Keleberda KIa; Svistunova AS; Kaminskaia GO; Kordonskaia VM
Probl Tuberk; 1982 Oct; (10):42-5. PubMed ID: 7178102
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
